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lization data. Results: The review allowed retrieving 4,768 studies and 11 fulfilled 
the eligibility criteria. Two articles presented their results in terms of correlation 
coefficient that were all statistically significant. The first one determined a correla-
tion between FEV1 and inhaled corticosteroids (ICS) use with an R-value of -0.42 and 
between sputum eosinophils and ICS use with an R-value of 0.3. The second article 
evaluated the correlation between PEF and hospitalization rates and concluded to 
a correlation with an R-value of -0.51. A total of 9 articles presented raw data that 
could be used to establish a correlation between lung function or eosinophil levels 
and resource utilization. Seven studies presented data that indicate an inverse cor-
relation between FEV1 and hospitalizations with decreased hospitalization rates, 
when FEV1 increases. Three studies indicate decreased emergency departments 
visit rates when FEV1 increases. Two studies also indicate an increased emergency 
department visit rates, when blood eosinophil levels increase. ConClusions: 
The correlation coefficients found in the systematic review indicate that when 
lung function improves or sputum eosinophil decreases, the resource utilization 
decreases. Furthermore, non-correlation studies that look at the same parameters 
support this hypothesis and suggest there may be a correlation between emergency 
department’s visits and blood eosinophil levels.
PRS79
The OPPORTuniTieS Of inTeRneT TechnOlOgy And Telemedicine in 
inTeRAcTiOn BeTween dOcTOR And PATienT
Namazova-Baranova L, Vishneva E, Smirnov V, Antonova E, Alekseeva A, Levina J, 
Efendieva K, Dobrynina E, Tomilova A, Voznesenskaya N, Selimzianova L, Promyslova E
Scientific Centre of Children Health, Moscow, Russia
objeCtives: The characteristic properties of the modern healthcare system are 
presented by integration of information technology capabilities and harmonization 
of their use in industry. Aim. To create new system of telecommunication interaction 
between doctor and patient – specialized internet portal. Methods: The study was 
carried out to create web portal. The software project - shell management website 
with two interfaces: for professionals and patients was developed. Simultaneously 
with design and creation of an internet portal, 156 children with bronchial asthma 
(BA) were examined and their medical data were reviewed. Results: 19 children 
with severe atopic persistent uncontrolled BA (68% boys; mean age 13.6; basic 
therapy - 875 mcg fluticasone in combination with long-acting ß2-agonist and 
Omalizumab, the average dose - 450 mg / 4 weeks) were included in the project and 
had received the personal individual access (a couple of unique login/password to 
own page). The personal page after entering the own individual login / password 
allows patient to type in synchronous/asynchronous mode indicators of peak flow, 
symptoms, using of basic therapy and rescue medication in a special tables, the 
level of asthma control (ACT- test), and remotely – to ask a question to specialist. 
Patients with severe BA exacerbations, who were in the intensive care unit, also 
patients who don’t perceive long-term significant decline in respiratory function, 
had issued devices to determine oxygen saturation (SpO2, pulsoximeter) to moni-
tor this indicator and to exclude development of life-threatening conditions. The 
specialist interface contains information about each patient to evaluate remotely 
in synchronous/asynchronous mode patient condition, therapy adherence and con-
trol of BA ConClusions: The results of preliminary analysis of using of this web 
portal show increase of adherence to prescribed treatment, improving of quality of 
life, reduction the incidence of exacerbations, that confirms clinical and economic 
feasibility of using internet technologies.
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objeCtives: Previous research to determine the effectiveness of web or computer 
based interventions, designed to reduce smoking have been reported. However, 
a lacuna regarding the use of same during consultations exists. The objective 
of this review was to improve understanding of the role of clinical computing 
systems during consultations on smoking cessation in general dental, medical, 
and community based practices or hospitals. Methods: The Cochrane Library, 
PubMed, ISI Web of Knowledge, EMBASE, and Google Scholar were accessed up to 
January 2010 using a combination of various Medical Subject Headings and other 
keywords to retrieve relevant studies not restricted to any geography. Studies 
were included based on a range of predefined inclusion criteria. Each study was 
quality scored (0-10) using a validated scoring system. The PRISMA checklist was 
used as the critical appraisal tool. Pre-developed forms were employed for extract-
ing the data. Results: Five studies fulfilled the selection criteria. A descriptive 
comparison was drawn between different studies since a meta-analysis was not 
possible as results for the I2 statistic were approximately 50%, indicating moder-
ate heterogeneity. A comparison of interventions was performed after extracting 
data from two studies using ExcelTM spread sheets, and presented as a forest 
plot. Findings indicated positive impact of clinical computing systems in physi-
cian consultations in increasing smoking abstinence in patients by 2% in clinical 
decision support system (CDSS) to up to 12 % (tailored letters). ConClusions: 
Tailored letters proved more effective when compared to brief advice and CDSS. 
Multi-faceted approaches involving elements of behavioral sciences, epide-
miology, health promotion and health informatics will be the key for future 
research.
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hospital admissions. Results: The study cohort included 36,914 patients (GOLD 
A: 33.8%, GOLD B: 21.0%, GOLD C: 18.1%, GOLD D: 27.0%). Average age at diagnosis 
was 66 years; 52.0% were male. Annual exacerbation rates increased with sever-
ity of COPD, ranging from GOLD A 0.83 (95% CI: 0.81–0.85) to GOLD D 2.51 (95% 
CI: 2.47–2.55) exacerbations per person-year (PPY). Annual rates of GP visits also 
increased with disease severity, from GOLD A 4.82 (95% CI: 4.74–4.93) to GOLD D 
7.44 (95% CI: 7.31–7.61) visits PPY. COPD-related hospitalisations increased with 
symptom severity from less (GOLD A: 0.28, GOLD C: 0.39 admissions PPY) to more 
symptoms (GOLD B: 0.52, GOLD D: 0.84 admissions PPY). No differences were 
observed across severity groups in non-COPD hospitalisations. ConClusions: 
Patients in the most severe category (GOLD D) experienced nearly three times the 
number of exacerbations and COPD-related hospital admissions as those in the 
least severe category (GOLD A). Management of COPD in earlier stages to stabilize 
disease progression could be beneficial for reducing exacerbation frequency and 
healthcare resource utilisation.
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objeCtives: To compare the total value of payer’s expenditures on Nutramigen 
LGG 1, Nutramigen LGG 2, Neocate LCP, Neocate Advance in patients with allergy to 
cow’s milk protein estimated in the manufacturers’ Budget Impact Analyses (BIAs) 
submitted with the reimbursement applications to AOTMiT and actual expenditures 
of the National Health Fund (NHF). Methods: Annual public payer’s expenditures 
estimated in manufacturers’ BIAs for Nutramigen LGG 1/2, Neocate LCP/Advance 
and actual expenditures reported by the NHF were compared. RSSs were not taken 
into account. Analysed drugs were chosen on the basis of the same indication. 
Actual expenditures and number of package were taken from the financial reports of 
the NHF for the first and second year of the reimbursement for each drug. Results: 
For drugs Nutramigen LGG1/2 and Neocate LCP/Advance in patients with allergy 
to cow’s milk protein, the sum of total expenditures estimated in BIA submitted 
with the reimbursement applications was 55,158 million PLN in the first year and 
57,637 million PLN in the second year, and they were higher than the actual expen-
ditures reported by the NHF: 5,3 million PLN and 16,14 million PLN, respectively. 
The expenditures estimated in BIAs were overestimated by 939% in the first year 
of the reimbursement and 257% in the second year of reimbursement. The number 
of packages of the Nutramigen LGG 1/2, Neocate LCP/Advance also were analysed. 
The number of reimbursed packages estimated in BIAs in comparison to its actual 
number from the NHF reports was overestimated by 2029% in the first year and 
492% in the second year of reimbursement. ConClusions: In the case of drugs 
chosen for this analysis, total payer’s expenditures estimated in BIAs submitted with 
the reimbursement applications were overestimated in comparison to the real life 
expenditures of the NHF in Poland.
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objeCtives: Patients with COPD in their final months of life place a potentially 
high burden upon healthcare systems. The aim of this systematic review was to 
describe the resources used and costs incurred by patients with COPD at the end-
of-life. Methods: We performed a comprehensive literature search in Medline, 
Web of Science and Econlit and evaluated and synthesized existing evidence on 
resource use and costs at the end-of-life in COPD patients. We screened 886 abstracts 
and reviewed 80 full-text manuscripts. Inclusion criteria were at least one type of 
resource use and/or cost outcome reported in adults diagnosed with COPD during an 
end-of-life period (varying between 3 years and 2 weeks before death). Subsequently, 
we performed quality appraisal consistent with the ISPOR checklist for retrospec-
tive database studies and accomplished comprehensive data extraction. Results: 
Nine studies fulfilled the inclusion criteria. Two, five and two studies described a 
European, North American and Asian healthcare setting, respectively. All studies 
had a retrospective design and were published between 2006 and 2014. We observed 
a very variable use of healthcare resources. An increased number of hospitaliza-
tions, ICU stay, primary care consultations and medication prescriptions and a lack 
of utilization of formal palliative care services were found to be the key drivers 
of resource use and costs of COPD patients during end-of-life. Palliative care also 
had a positive impact on costs in those patients. ConClusions: Despite a small 
number of existing studies, we found that the extensive and variable resource use 
and related costs of COPD patients during end-of-life applies to different aspects 
of the healthcare system. Especially the use of palliative care services is presumed 
to be effective in cost reduction at the end-of-life.
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objeCtives: Asthma is a very common chronic disease that can cause a significant 
economic burden. The objective of this review was to explore the evidence on the 
possible correlation between lung function or eosinophil levels and resource utiliza-
tion in asthmatic patients. Methods: A literature search was made using keywords 
such as “asthma”, “eosinophil”, “respiratory function”, “resources”, and “costs”. The 
search was conducted in the electronic databases MEDLINE, EMBASE and PubMed 
from January 2000 to February 10th, 2015. To be eligible, studies had to focus on asth-
matic patients, include pulmonary or eosinophil measurements, and resource uti-
